Abstract:In China, there has been a persistent upward trend in the incidence and mortality rates of colorectal cancer (CRC), with CRC ranking second in incidence and fifth in mortality among all malignant tumors. Although circular RNAs (circRNAs) have been implicated in the progression of various cancers, their specific role in CRC progression remains largely unexplored. The objective of this study was to elucidate the role and underlying mechanisms of circXRN2 in CRC. Differential expression of circXRN2 was identified through whole transcriptome sequencing. The expression levels of circXRN2 and miR-149-5p were quantified in CRC tissues, corresponding adjacent normal tissues, and CRC cell lines using quantitative reverse transcription-polymerase chain reaction (qRT-PCR). The stability of circXRN2 was confirmed through RNase R and actinomycin D experiments. The binding interaction between circXRN2 and miR-149-5p was validated through RNA pull-down, RNA immunoprecipitation, and dual-luciferase assays. The biological functions of circXRN2 were assessed through a battery of in vitro experiments, including the CCK-8 assay, EdU assay, scratch assay, Transwell assay, and flow cytometry assay. Additionally, in vivo experiments involving a tumor transplantation model and a liver-lung metastasis model were conducted. The influence of circXRN2 on the expression of epithelial–mesenchymal transition (EMT)-related genes was determined via Western blotting analysis. In CRC tissues and cells, there was an upregulation in the expression levels of both circXRN2 and ENC1, while miR-149-5p exhibited a downregulation in its expression. The overexpression of circXRN2 was found to enhance tumor proliferation and metastasis, as evidenced by results from both in vitro and in vivo experiments. Functionally, circXRN2 exerted its antitumor effect by suppressing cell proliferation, migration, and invasion while also promoting apoptosis. Mechanistically, the dysregulated expression of circXRN2 had an impact on the expression of proteins within the EMT signaling pathway. Our results demonstrated that circXRN2 promoted the proliferation and metastasis of CRC cells through the miR-149-5p/ENC1/EMT axis, suggesting that circXRN2 might serve as a potential therapeutic target and novel biomarker in the progression of CRC.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of circular RNA (circXRN2) in the progression of colorectal cancer (CRC) and its underlying mechanisms. Specifically, researchers discovered through whole - transcriptome sequencing that the expression of circXRN2 was significantly up - regulated in CRC tissues, and further explored how circXRN2 accelerates the progression of CRC by regulating the miR - 149 - 5p/MACC1 axis and epithelial - mesenchymal transition (EMT). The main objective of the study was to elucidate the biological function of circXRN2 in CRC and its potential as a therapeutic target and a novel biomarker. ### Main research contents and methods: 1. **Expression analysis of circXRN2**: - Identify differentially expressed circRNAs in five pairs of CRC tissues and their corresponding normal tissues through whole - transcriptome sequencing. - Use qRT - PCR to verify the expression levels of circXRN2 in 100 pairs of CRC tissues and normal tissues. - Conduct survival analysis to evaluate the relationship between circXRN2 expression levels and patient prognosis. 2. **Stability and localization of circXRN2**: - Confirm the stability of circXRN2 through RNase R and actinomycin D experiments. - Determine that circXRN2 is mainly located in the cytoplasm through nuclear - cytoplasmic separation experiments. 3. **Functional study of circXRN2**: - Knock down and over - express circXRN2 by synthesizing siRNAs and over - expression plasmids respectively, and evaluate their effects on CRC cell proliferation, migration, invasion and apoptosis. - Use CCK - 8, EdU, flow cytometry, scratch assay and Transwell assay for functional verification. 4. **In vivo experiments of circXRN2**: - Establish subcutaneous xenograft tumor models and tail vein injection metastasis models to evaluate the role of circXRN2 in vivo. - Evaluate tumor growth and metastasis through Ki67 immunohistochemistry and H&E staining. 5. **Interaction between circXRN2 and miR - 149 - 5p**: - Use dual - luciferase reporter gene assay, RNA pull - down assay and RNA immunoprecipitation (RIP) assay to verify the binding between circXRN2 and miR - 149 - 5p. - Explore how circXRN2 inhibits miR - 149 - 5p through a sponge effect, thereby affecting the expression of EMT - related proteins. ### Main conclusions: - The expression of circXRN2 in CRC tissues and cells is significantly up - regulated, and high expression is associated with a poor prognosis. - circXRN2 promotes the expression of MACC1 by inhibiting the expression of miR - 149 - 5p, thereby accelerating the proliferation and metastasis of CRC. - circXRN2 also promotes the migration and invasion of CRC cells by affecting the expression of EMT - related proteins. - In vivo experiments further confirm the tumor - promoting role of circXRN2 in CRC, suggesting that it may become a potential therapeutic target and biomarker for CRC. In conclusion, this study systematically reveals the important role of circXRN2 in the progression of CRC and its molecular mechanisms, providing new ideas for the early diagnosis and treatment of CRC.

CircXRN2 accelerates colorectal cancer progression through regulating miR-149-5p/MACC1 axis and EMT

CircCTNNA1 Acts As a Cerna for Mir-363-3p to Facilitate the Progression of Colorectal Cancer by Promoting CXCL5 Expression

Hsa_Circ_0066351 Acts as a Prognostic and Immunotherapeutic Biomarker in Colorectal Cancer

Exosomal circZFR promotes colorectal cancer progression via interacting with BCLAF1 and regulating the miR-3127-5p/RTKN2 axis

CircZFR promotes colorectal cancer progression via stabilizing BCLAF1 and regulating the miR-3127-5p/RTKN2 axis

Circular RNA circCTNNA1 promotes colorectal cancer progression by sponging miR-149-5p and regulating FOXM1 expression

Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis

Circ_0004585 Facilitates Tumorigenesis of Colorectal Cancer Via Modulating the miR-338-3p/ZFX Axis and Activating the MEK/ERK Pathway

Circular RNA circ_0007142 Facilitates Colorectal Cancer Progression by Modulating CDC25A Expression via miR-122-5p

circEIF3I Promotes Colorectal Cancer Metastasis by Regulating the miR‐328‐3p/NCAPH Axis

Circular RNA (circ)_0053277 Contributes to Colorectal Cancer Cell Growth, Angiogenesis, Metastasis and Glycolysis

CircRNA_0084927 promotes colorectal cancer progression by regulating miRNA-20b-3p/glutathione S-transferase mu 5 axis

CircRNA_002178 as a ceRNA promotes the development of colorectal cancer by regulating miR-542-3p/CREB1

Circular RNA circ_0000372 contributes to the proliferation, migration and invasion of colorectal cancer by elevating IL6 expression via sponging miR-495.

A Novel Circfmn2 Promotes Tumor Proliferation in CRC by Regulating the Mir-1182/Htert Signaling Pathways

Circ_0006168 Promotes the Migration, Invasion and Proliferation of Esophageal Squamous Cell Carcinoma Cells via miR-516b-5p-Dependent Regulation of XBP1

CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis

Circ_ 0115744 acts as miR-144 sponge to promote and predict the metastasis of colorectal cancer

Circ_0000395 promotes cell growth, metastasis and oxaliplatin resistance by regulating miR-153-5p/MYO6 in colorectal cancer

Circ3823 contributes to growth, metastasis and angiogenesis of colorectal cancer: involvement of miR-30c-5p/TCF7 axis

Circular RNA circ_0089153 acts as a competing endogenous RNA to regulate colorectal cancer development by the miR-198/SUMO-specific peptidase 1 (SENP1) axis